Berman Capital Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.5M Sell
34,890
-4,310
-11% -$191K 0.24% 52
2021
Q2
$1.53M Buy
39,200
+10,013
+34% +$389K 0.24% 50
2021
Q1
$1.06M Buy
29,187
+2,173
+8% +$77.2K 0.22% 58
2020
Q4
$993K Buy
27,014
+270
+1% +$9.9K 0.24% 54
2020
Q3
$930K Buy
26,744
+3,362
+14% +$118K 0.26% 49
2020
Q2
$724K Sell
23,382
-3,978
-15% -$135K 0.19% 56
2020
Q1
$846K Buy
27,360
+10,457
+62% +$356K 0.27% 43
2019
Q4
$627K Buy
16,903
+1,633
+11% +$58.2K 0.18% 59
2019
Q3
$520K Sell
15,270
-2,422
-14% -$88.1K 0.16% 66
2019
Q2
$726K Buy
17,692
+1,103
+7% +$43.8K 0.23% 49
2019
Q1
$668K Sell
16,589
-384
-2% -$15.4K 0.22% 50
2018
Q4
$702K Buy
16,973
+4,182
+33% +$174K 0.28% 40
2018
Q3
$516K Sell
12,791
-2,074
-14% -$79.8K 0.22% 56
2018
Q2
$509K Buy
14,865
+473
+3% +$16.2K 0.18% 62
2018
Q1
$485K Buy
14,392
+1,843
+15% +$63.4K 0.18% 56
2017
Q4
$429K Buy
+12,549
New +$428K 0.14% 64

Other funds holding PFE

Berman Capital Advisors's PFE Position: Q3 2021 in Review

Berman Capital Advisors reduced its Pfizer (PFE) stake by 11% in Q3 2021, selling an estimated $191K and leaving 34,890 shares worth $1.5M. The position accounts for 0.24% of the portfolio, ranked #52.

Berman Capital Advisors first reported a position in PFE in Q4 2017 and has held it in 16 quarters since. The position peaked at $1.53M in Q2 2021. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • Berman Capital Advisors held 34,890 shares of Pfizer worth $1.5M as of Q3 2021.
  • Berman Capital Advisors sold 4,310 Pfizer shares in Q3 2021, an estimated $191K.
  • Pfizer made up 0.24% of Berman Capital Advisors's portfolio in Q3 2021, its #52 holding.
  • Berman Capital Advisors first reported a position in Pfizer in Q4 2017 and has held it in 16 quarters since.
  • Berman Capital Advisors's Pfizer position peaked at $1.53M in Q2 2021.
  • 2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.